The tuberous sclerosis complex: a comprehensive review

作者: DavidM Weiner , DavidH Ewalt , E.Steve Roach , TerryW Hensle

DOI: 10.1016/S1072-7515(98)00239-7

关键词: DiseaseAdenoma sebaceumSoft tissueConsensus conferenceEpilepsySubependymal zoneMedicinePathologyTuberous sclerosisSystemic disease

摘要: Tuberous sclerosis was first reported by von Recklinghausen in 1862 and named Bourneville 1880. Transmission is autosomal dominant, but roughly 65% to 85% of the patients arise via spontaneous mutation. The incidence tuberous estimated between 1:6,000 1:10,000 individuals. notion “classic triad” epilepsy, mental retardation, facial angiofibromata (adenoma sebaceum) has been frequently cited literature. However, few affected individuals develop all aforementioned signs, emphasis these limited features misleading. It seems more appropriate recognize that complex may present as a wide spectrum disease. diagnostic criteria for Sclerosis Complex were revised subcommittee at recent Consensus Conference. These clinical are outlined Table 1. Pathologically, disorder cellular migration, proliferation, differentiation. Manifestations be systemic variable. A variety associated lesions have literature including subependymal brain nodules calcifications, astrocytomas, retinal phacomas, sclerotic bone lesions, dental enamel pitting, hamartomatous or cystic brain, heart, lungs, kidneys, spleen, liver, uterus, soft tissues. Although many manifestations secondary growths, true neoplasms do occur, particularly kidneys brain. Depending on degree expression organ involvement specifically, select experience significant morbidity mortality. Advances genetics, imaging modalities, medical therapies, surgical techniques unmasked some mysteries surrounding this fascinating and, undoubtedly, will continue affect complications.

参考文章(85)
Thomas J. Stillwell, Manuel R. Gomez, Panayotis P. Kelalis, Renal lesions in tuberous sclerosis The Journal of Urology. ,vol. 138, pp. 477- 481 ,(1987) , 10.1016/S0022-5347(17)43234-4
Michael L. Blute, Reza S. Malek, Joseph W. Segura, Angiomyolipoma: Clinical Metamorphosis and Concepts for Management The Journal of Urology. ,vol. 139, pp. 20- 24 ,(1988) , 10.1016/S0022-5347(17)42276-2
David L. McCullough, Russell Scott, Herbert M. Seybold, Renal Angiomyolipoma (Hamartoma): Review of the Literature and Report of 7 Cases The Journal of Urology. ,vol. 105, pp. 32- 44 ,(1971) , 10.1016/S0022-5347(17)61455-1
Joseph E. Oesterling, Elliot K. Fishman, Stanford M. Goldman, Fray F. Marshall, The management of renal angiomyolipoma. The Journal of Urology. ,vol. 135, pp. 1121- 1124 ,(1986) , 10.1016/S0022-5347(17)46013-7
Mitchell S. Steiner, Stanford M. Goldman, Elliot K. Fishman, Fray F. Marshall, The Natural History of Renal Angiomyolipoma The Journal of Urology. ,vol. 150, pp. 1782- 1786 ,(1993) , 10.1016/S0022-5347(17)35895-0
James R. Taylor, Jay Ryu, Thomas V. Colby, Thomas A. Raffin, Lymphangioleiomyomatosis. Clinical course in 32 patients. The New England Journal of Medicine. ,vol. 323, pp. 1254- 1260 ,(1990) , 10.1056/NEJM199011013231807
J.G. Van Baal, N.J. Smits, J.N. Keeman, D. Lindhout, S. Verhoef, The Evolution of Renal Angiomyolipomas in Patients with Tuberous Sclerosis Journal of Urology. ,vol. 152, pp. 35- 38 ,(1994) , 10.1016/S0022-5347(17)32809-4
Joseph Kochen, Joseph Kochen, Mark E. Weinblatt, Ellen Kahn, Ellen Kahn, Renal cell carcinoma in patients with tuberous sclerosis. Pediatrics. ,vol. 80, pp. 898- 903 ,(1987)
J. M. Bonnin, L. J. Rubinstein, S. Ch. Papasozomenos, P. J. Marangos, Subependymal giant cell astrocytoma Acta Neuropathologica. ,vol. 62, pp. 185- 193 ,(1984) , 10.1007/BF00691851
D J Kwiatkowski, J Bjornsson, E P Henske, M P Short, Tuberous sclerosis-associated renal cell carcinoma : Clinical, pathological, and genetic features American Journal of Pathology. ,vol. 149, pp. 1201- 1208 ,(1996)